Elaine McCartney

563 total citations
17 papers, 388 citations indexed

About

Elaine McCartney is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Elaine McCartney has authored 17 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Elaine McCartney's work include Central Venous Catheters and Hemodialysis (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Vascular Malformations and Hemangiomas (3 papers). Elaine McCartney is often cited by papers focused on Central Venous Catheters and Hemodialysis (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Vascular Malformations and Hemangiomas (3 papers). Elaine McCartney collaborates with scholars based in United Kingdom, Malaysia and Australia. Elaine McCartney's co-authors include Ross Carruthers, Jennifer R. Brown, Lye Mun Tho, A. McDonald, James Paul, Olívia Wu, Judith Dixon-Hughes, Jonathan Moss, Brian Jones and Roshan Agarwal and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Elaine McCartney

16 papers receiving 381 citations

Peers

Countries citing papers authored by Elaine McCartney

Since Specialization

Citations

This map shows the geographic impact of Elaine McCartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine McCartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine McCartney more than expected).

Fields of papers citing papers by Elaine McCartney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine McCartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine McCartney. The network helps show where Elaine McCartney may publish in the future.

Co-authorship network of co-authors of Elaine McCartney

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine McCartney. A scholar is included among the top collaborators of Elaine McCartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine McCartney. Elaine McCartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	LBA100 CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes 2023 ·Annals of Oncology ·Harpreet Wasan, Jiazhao Wang, Elaine McCartney, Harris S. Soifer, Kai Treuner, (unknown), Catherine A. Schnabel, Karen Carty, Lynn McMahon, T.R. Jeffry Evans, M. Nicolson, Helene Thygesen, (unknown), Karin A. Oien	2
2	Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic Evaluation 2023 ·Value in Health ·Robert Heggie, Nishant Jaiswal, Elaine McCartney, Jon Moss, Tobias Menne, Brian Jones, Kathleen Boyd, (unknown), Neil Hawkins, Olívia Wu	3
3	Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer 2022 ·British Journal of Urology ·Linda Rushworth, Carolyn J. Loveridge, Mark J. Salji, (unknown), Ernest Mui, David Sumpton, Matthew Neilson, Ann Hedley, Laura E. Crotty Alexander, Elaine McCartney, Rachana Patel, Jan Wallace, Christian Delles, Robert J. Jones, Hing Y. Leung	5
4	Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT 2021 ·Health Technology Assessment ·Olívia Wu, Elaine McCartney, Robert Heggie, Evi Germeni, James Paul, (unknown), Susan Dillon, (unknown), (unknown), Judith Dixon-Hughes, Roshan Agarwal, Andrew Bodenham, Tobias Menne, Brian Jones, Jonathan Moss	14
5	Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial 2021 ·The Lancet ·Jonathan Moss, Olívia Wu, Andrew Bodenham, Roshan Agarwal, Tobias Menne, Brian Jones, Robert Heggie, Steve Hill, Judith Dixon-Hughes, (unknown), Evi Germeni, Susan Dillon, Elaine McCartney	74
6	A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC). 2020 ·Journal of Clinical Oncology ·T.R. Jeffry Evans, Martin Eatock, Liz-Anne Lewsley, Caroline Kelly, Elaine McCartney, Aileen Duffton, (unknown), Claire Harrison, Colin Purcell, Miranda Ashton, (unknown), (unknown), Anthony J. Chalmers, Fiona Thomson, Chantévy Pou, Alan Bilsland, (unknown), David E. McIntosh, Derek Grose	4
7	Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study 2019 ·BMJ Open ·M. Hatton, (unknown), Corinne Faivre‐Finn, David Landau, J.F. Lester, John D. Fenwick, Rita Simões, Elaine McCartney, Kathleen Boyd, Tom Haswell, Ann Shaw, James Paul	9
8	Dynamics of circulating vascular endothelial growth factor‐A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients 2019 ·British Journal of Clinical Pharmacology ·Cong Zhou, Sarah Taylor, Jonathan Tugwood, Kathryn Simpson, Gordon C. Jayson, Paul Symonds, James Paul, S.E. Davidson, Karen Carty, Elaine McCartney, (unknown), Caroline Dive, Catharine West	3
9	Abstract CT027: Safety, pharmacokinetics (PK) & pharmacodynamics (PD) of idasanutlin (idasa), combined with abiraterone (abi)/prednisolone (pred) or enzalutamide (enza) in castrate resistant prostate cancer (CRPC) 2018 ·Cancer Research ·Patricia Roxburgh, (unknown), (unknown), Caroline Kelly, (unknown), Carol McCormick, Alan Bilsland, Robert H. Jones, (unknown), Elaine McCartney, (unknown), Robert J. Jones	2
10	171: ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer (NSCLC) 2017 ·Lung Cancer ·(unknown), (unknown), Corinne Faivre‐Finn, Kathleen Boyd, J.F. Lester, John D. Fenwick, J. Maguire, Elaine McCartney, James Paul, (unknown), (unknown), Tom Haswell, M. Hatton	0
11	Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation 2016 ·British Journal of Cancer ·Olívia Wu, Kathleen Boyd, James Paul, Elaine McCartney, (unknown), (unknown), Linda J Kelly, Judith Dixon-Hughes, Jon Moss	34
12	A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer 2015 ·Supportive Care in Cancer ·Rebecca Marshall, Audrey Morrison, (unknown), C. Hutchison, (unknown), (unknown), Lorna Paul, Marc Rodger, Iain R. Macpherson, Elaine McCartney	11
13	Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial 2015 ·The Lancet Oncology ·R.P. Symonds, Charlie Gourley, S.E. Davidson, Karen Carty, Elaine McCartney, (unknown), Susana Banerjee, David Jackson, Rosemary Lord, Mary McCormack, Emma Hudson, Nicholas S. Reed, M. Flubacher, Petra Jankowska, Melanie Powell, Caroline Dive, Catharine West, James Paul	84
14	Clinical Outcomes from the Uk Cup-One Study: a Multi-Centre Trial to Assess the Efficacy of Epirubicin, Cisplatin and Capecitabine (Ecx) in Carcinomas of Unknown Primary (Cup) with Prospective Validation of Molecular Classifiers 2014 ·Annals of Oncology ·Harpreet Wasan, James Paul, M. Nicolson, T.R. Jeffry Evans, Lynn McMahon, Anna Morris, Elaine McCartney, (unknown), David D.L. Bowtell, Mark G. Erlander, Karin Oien	1
15	Circca: a Randomised Double Blind Phase Ii Trial of Carboplatin-Paclitaxel Plus Cediranib Versus Carboplatin-Paclitaxel Plus Placebo in Metastatic/Recurrent Cervical Cancer. (Cruk Grant Ref: C1256/A11416) 2014 ·Annals of Oncology ·Paul Symonds, Charlie Gourley, S.E. Davidson, Catharine West, Caroline Dive, James Paul, Karen Carty, Elaine McCartney, (unknown), Susana Banerjee, David Jackson, Rosemary Lord, Mary McCormack, Emma Hudson, Nicholas S. Reed, M. Flubacher, (unknown), Melanie Powell	7
16	Prostate Gland Lengths and Iceball Dimensions Predict Micturition Functional Outcome Following Salvage Prostate Cryotherapy in Men with Radiation Recurrent Prostate Cancer 2013 ·PLoS ONE ·Imran Ahmad, Gabriela Kalna, Mohamed Ismail, (unknown), (unknown), Elaine McCartney, Damien Greene, John Davies, Hing Y. Leung	12
17	Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer 2012 ·Colorectal Disease ·Ross Carruthers, Lye Mun Tho, Jennifer R. Brown, (unknown), Elaine McCartney, A. McDonald	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact